Europe In-Vitro Fertilization (IVF) Market is anticipated to be valued at USD 1.75 Billion by 2023.
Based on reagents & media, the market is further sub-segmented as embryo culture media, cryopreservation media, sperm processing media, and ovum processing media.
(EMAILWIRE.COM, September 27, 2018 ) Overview:
In the year 2018, Europe In-Vitro Fertilization (IVF) Market was valued at USD 0.85 Billion. By the year 2023, it is expected to reach USD 1.75 Billion at pace of 12.95% CAGR.
In-vitro fertilization is the process by which infertility and other genetic problems are treated by artificial fertilization. IVF is the process of fertilization by extracting eggs, retrieving a sperm sample, and then manually combining an egg and sperm in a laboratory dish. The embryo is then transferred to the uterus. This process has become the most preferred option for effective fertility treatments and assisted reproduction techniques (ART), which offer solutions to couples and single parents.
View sample and decide: https://www.marketdataforecast.com/market-reports/europe-in-vitro-fertilization-market-300/request-sample
Underlying Causes
The growth for In-Vitro Fertilization (IVF) Market is driven due to factors like increasing incidence of infertility, growing adoption of in-vitro fertilization babies among population, rising demand for IVF, increasing disposable income. In addition, government funding to encourage egg/sperm freezing, technological advancements and rising late stage marriages are expected to drive the market growth. However, high cost of treatment and stringent government policies are expected to hamper the growth rate for Europe In-Vitro Fertilization (IVF) Market during the forecast period.
To know more read: https://www.marketdataforecast.com/market-reports/europe-in-vitro-fertilization-market-300/
Geographic Segmentation:
Based on geography the Europe In-Vitro Fertilization (IVF) Market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. Europe holds the largest market share in the In-Vitro Fertilization (IVF) Market due to due to availability of quality treatment offered at low cost, increasing incidence of infertility, and government initiatives to provide better reimbursement policies are the driving factors in this region.
Get your customized report: https://www.marketdataforecast.com/market-reports/europe-in-vitro-fertilization-market-300/customize-report
Key Players:
Leading companies for Europe In-Vitro Fertilization (IVF) Market are CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and The Baker Company, Inc. (U.S.)
In the year 2018, Europe In-Vitro Fertilization (IVF) Market was valued at USD 0.85 Billion. By the year 2023, it is expected to reach USD 1.75 Billion at pace of 12.95% CAGR.
In-vitro fertilization is the process by which infertility and other genetic problems are treated by artificial fertilization. IVF is the process of fertilization by extracting eggs, retrieving a sperm sample, and then manually combining an egg and sperm in a laboratory dish. The embryo is then transferred to the uterus. This process has become the most preferred option for effective fertility treatments and assisted reproduction techniques (ART), which offer solutions to couples and single parents.
View sample and decide: https://www.marketdataforecast.com/market-reports/europe-in-vitro-fertilization-market-300/request-sample
Underlying Causes
The growth for In-Vitro Fertilization (IVF) Market is driven due to factors like increasing incidence of infertility, growing adoption of in-vitro fertilization babies among population, rising demand for IVF, increasing disposable income. In addition, government funding to encourage egg/sperm freezing, technological advancements and rising late stage marriages are expected to drive the market growth. However, high cost of treatment and stringent government policies are expected to hamper the growth rate for Europe In-Vitro Fertilization (IVF) Market during the forecast period.
To know more read: https://www.marketdataforecast.com/market-reports/europe-in-vitro-fertilization-market-300/
Geographic Segmentation:
Based on geography the Europe In-Vitro Fertilization (IVF) Market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. Europe holds the largest market share in the In-Vitro Fertilization (IVF) Market due to due to availability of quality treatment offered at low cost, increasing incidence of infertility, and government initiatives to provide better reimbursement policies are the driving factors in this region.
Get your customized report: https://www.marketdataforecast.com/market-reports/europe-in-vitro-fertilization-market-300/customize-report
Key Players:
Leading companies for Europe In-Vitro Fertilization (IVF) Market are CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and The Baker Company, Inc. (U.S.)
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results